Not all patients with CLL have to have therapy. Inspite of all modern improvements, the iwCLL continue to suggests watchful observation for people with asymptomatic condition.86 This advice is predicated on no less than two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (F